GENERAL ELECTRIC CO
GENERAL ELECTRIC CO (GE) Stock News
The latest GE headlines and market coverage — 30 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
AEVEX URGENT DEADLINE ALERT: AEVEX Corp. Investors Have Until October 20th to Seek Lead Plaintiff Role with Bragar Eagel & Squire, P.C.
A class action lawsuit has been filed against AEVEX Corp. alleging that the company and underwriters concealed a pre-arranged plan to prematurely override a 180-day lock-up agreement following its April 2026 IPO. The alleged scheme would have allowed Madison (the majority shareholder) to conduct a secondary public offering worth over $200 million shortly after the IPO. Investors who purchased shares during the IPO or between April 17 and June 4, 2026 have until October 20, 2026 to apply as lead plaintiff.
- The Motley Fool·
GE Aerospace vs. Lockheed Martin: Which Stock Is a Better Buy in 2026?
GE Aerospace and Lockheed Martin represent two distinct aerospace investment strategies. GE Aerospace benefits from a commercial aviation boom with strong revenue growth (18.5% YoY), high margins (19%), and a $210B+ backlog. Lockheed Martin offers stability through defense contracts with 72% U.S. Government revenue, though slower growth (5.7% YoY) and higher leverage (3.2x debt-to-equity). The article recommends GE Aerospace for growth-focused investors seeking rapid cash generation, while Lockheed Martin suits those preferring steady, predictable dividend returns.
- GlobeNewswire Inc.·
TBLA URGENT DEADLINE: Bragar Eagel & Squire, P.C. Urges Taboola.com Ltd. Investors with Large Losses to Contact the Firm Before the October 20th Lead Plaintiff Deadline
Bragar Eagel & Squire, P.C. has filed class action lawsuits against Taboola.com Ltd. and GoDaddy Inc. on behalf of investors who suffered losses during specified periods. Taboola.com is accused of making materially false statements regarding low-quality publishers and overstated publisher relationship values. Investors have until October 20, 2026 to apply to be appointed as lead plaintiff in these cases.
- The Motley Fool·
Stock-Split Watch: Is GE Vernova Next?
GE Vernova stock has surged sevenfold since its April 2024 spinoff from General Electric, trading above $1,000 per share. With a $176 billion order backlog, strong free cash flow generation ($5.1B in Q2), and expanding margins, the company's strong fundamentals have led analysts to speculate whether a stock split may be forthcoming. While stock splits don't change company value, they can signal management confidence and improve accessibility to retail investors.
- GlobeNewswire Inc.·
CREDIT AGRICOLE SA: CRÉDIT AGRICOLE ACCELERATES ITS EXPANSION IN GERMANY AND SIGNS AN AGREEMENT TO ACQUIRE IKB DEUTSCHE INDUSTRIEBANK
Crédit Agricole has signed an agreement to acquire 100% of IKB Deutsche Industriebank AG from Lone Star Funds for €14.3 billion in total assets. The acquisition is a strategic move to accelerate Crédit Agricole's expansion in Germany's mid-corporate banking market, particularly targeting the Mittelstand. The transaction is expected to close by end of Q2 2027 and will have a negative impact of approximately 20 basis points on Crédit Agricole's CET1 ratio.
- The Motley Fool·
Boeing vs. GE Aerospace: Which U.S. Industrial Giant's Stock Is a Better Buy in 2026?
GE Aerospace emerges as the better investment choice in 2026 compared to Boeing. While Boeing boasts a massive order backlog and leading position in commercial aviation, it struggles with negative free cash flow, a 10x debt-to-equity ratio, and declining profitability forecasts. GE Aerospace, conversely, demonstrates strong fundamentals with a 19% net margin, $7.3 billion in free cash flow, and a more reasonable valuation multiple, supported by recent major contracts from airlines and the U.S. military.
- Zacks Investment Research·
VLGEA Stock Falls 3% as Q4 Earnings Decline Y/Y Amid Rising Costs
Village Super Market (VLGEA) reported fourth-quarter fiscal 2026 earnings of 92 cents per share, down 12.4% year-over-year, despite revenues rising 1.7% to $609.6 million. Net income declined 12.3% to $13.6 million. While same-store sales grew 1.6% and digital sales increased 6%, the company faced headwinds from rising operating costs, higher employee expenses, and egg price deflation. Full-year fiscal 2026 net income fell to $52.5 million from $56.4 million despite 3.7% sales growth.
- GlobeNewswire Inc.·
URGENT AARDVARK DEADLINE: Bragar Eagel & Squire, P.C. Urges Aardvark Therapeutics, Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 13th
A class action lawsuit has been filed against Aardvark Therapeutics in the U.S. District Court for the Southern District of California. The lawsuit alleges that defendants made materially false and misleading statements in the company's IPO registration statement and throughout the class period (February 13, 2025 to May 14, 2026), specifically regarding the safety and commercial prospects of their drug ARD-101. Investors who purchased shares during this period can apply to be lead plaintiff by October 13, 2026.
- GlobeNewswire Inc.·
SMPL URGENT DEADLINE: Bragar Eagel & Squire, P.C. Urgently Reminds The Simply Good Foods Company Investors of The Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm Before October 13th
A class action lawsuit has been filed against The Simply Good Foods Company for allegedly making false statements regarding its OWYN acquisition. The lawsuit claims the company lost key personnel post-acquisition, faced product quality issues with a new pea protein supplier, engaged in excessive discounting to boost sales, and ultimately failed to achieve strategic goals, resulting in significant operational and financial problems for the OWYN segment.
- GlobeNewswire Inc.·
Sigenergy Unveils the Latest Energy Solutions at Malaysia’s IGEM 2026
Sigenergy showcased its latest intelligent energy solutions at IGEM Malaysia, delivering a keynote on AI-driven innovation in smart energy systems. The company signed MOUs with strategic partners Milieu and YT Energy to accelerate adoption of advanced energy solutions in Malaysia, while displaying its residential, C&I, and utility products including SigenStor Neo, SigenStack, and the Sigen PV 500H1 inverter.
- Zacks Investment Research·
Geo Group (GEO) Upgraded to Strong Buy: What Does It Mean for the Stock?
Geo Group has been upgraded to a Zacks Rank #1 (Strong Buy) rating, reflecting upward trends in earnings estimates. The private prison operator is positioned in the top 5% of Zacks-covered stocks based on estimate revisions, suggesting potential near-term stock price appreciation. Analysts have raised consensus estimates by 10.8% over the past three months.
- Zacks Investment Research·Neutral
GE Vernova (GEV) Dips More Than Broader Market: What You Should Know
GE Vernova (GEV) closed down 3.12% but has gained 5.96% over the past month. The energy spinoff from General Electric is expected to report earnings on October 28, 2026, with projected EPS growth of 149.39% and revenue growth of 21.39% year-over-year. However, the stock trades at a premium valuation with a Forward P/E of 35.53 versus the industry average of 17.95, earning a Zacks Rank of #3 (Hold).
- The Motley Fool·
Only 20% of GE Vernova's Order Book Is Data Centers. Here's Why That's the Bull Case, Not the Risk.
GE Vernova derives only 20% of its power-generation backlog from AI data centers, with the remaining 80% coming from traditional customers like utilities and refineries. While AI demand provides pricing power, the company's diversified customer base insulates it from AI market volatility. With global electricity demand expected to grow 3.6-3.8% annually through 2027, driven by EVs and other factors beyond AI, GE Vernova is positioned for sustainable long-term growth, with Morningstar projecting 2030 revenue of $78.6 billion versus $38.1 billion in 2025.
- The Motley Fool·
Where Will GE Vernova Stock Be in 5 Years?
GE Vernova, spun off from General Electric in April 2024, has seen its stock surge sevenfold to around $1,000 per share. The company benefits from AI and cloud computing demand driving growth in its Power and Electrification segments, with a massive $176.3 billion backlog. Analysts project 17% revenue and 60% adjusted EBITDA growth through 2028, suggesting the stock could more than triple over the next five years.
- GlobeNewswire Inc.·
OR Royalties Announces Preliminary Q3 2026 GEO Deliveries
OR Royalties Inc. announced Q3 2026 preliminary results showing 20,237 attributable gold equivalent ounces earned, with revenues of $90.2 million and a cash margin of $87.3 million (96.8%). The company maintained a cash position of $76.7 million after share repurchases and completed the La Verde royalty acquisition for $15.0 million. The revolving credit facility had $228.2 million drawn with $621.8 million available capacity.
- The Motley Fool·
Why GE Vernova Stock Trounced the Market Today
GE Vernova stock surged nearly 4% after Oppenheimer analyst Colin Rusch named it the top stock pick in the power engineering sector. The analyst cited strong growth driven by AI infrastructure buildout and President Trump's executive order banning Chinese bulk power equipment imports, which gives GE Vernova significant pricing power and competitive advantage.
- CNBC·
What's behind an 'explosion of buying' Tuesday, including the rally in GE Vernova
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
- The Motley Fool·
NuScale vs. Oklo vs. GE Vernova: Ranking 3 Nuclear Stocks By Backlog, Not Hype.
Three publicly traded small modular reactor (SMR) companies are positioned to benefit from AI data center power demands. Oklo has the largest backlog (18.1 GW) but much is nonbinding; NuScale offers traditional utility-focused approach with 6-7 GW backlog concentrated with one customer; GE Vernova has the highest quality backlog with active construction projects but weakest SMR exposure at under 3% of sales.
- GlobeNewswire Inc.·
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz is investigating GE HealthCare Technologies for potential federal securities law violations. The investigation follows the company's April 2026 earnings report, which revealed a PDx supplier recall that impacted profit performance and margins, leading to reduced full-year EPS guidance and a 13.2% stock price decline. The company's CFO also stepped down in July 2026.
- GlobeNewswire Inc.·
DATAVAULT URGENT INVESTOR DEADLINE ALERT: Datavault AI Inc. Investors Have Until October 5th to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role
A class action lawsuit has been filed against Datavault AI Inc. (NASDAQ: DVLT) for allegedly making materially false and misleading statements regarding corporate partnerships, trading volume on its platform, and undisclosed connections to a convicted felon. Investors who purchased securities between September 4, 2024 and October 30, 2025 have until October 5, 2026 to apply for lead plaintiff status.
- The Motley Fool·
Why GE Vernova Stock Crushed it Today
GE Vernova stock rose nearly 4% after analyst Alex Virgo from Evercore ISI reiterated his outperform rating and raised 2027-2028 EPS growth estimates by 3-4%. Virgo maintains a $1,350 price target, implying 37% upside, citing strong momentum and an expected $200 billion backlog next year driven by AI data center power generation equipment demand.
- The Motley Fool·Neutral
GE Aerospace vs. SpaceX: Which Aerospace Giant Is a Better Stock Buy in 2026?
GE Aerospace and SpaceX represent contrasting investment profiles in the aerospace sector. GE Aerospace demonstrates strong profitability with a 19% net margin and $7.3B free cash flow, trading at a reasonable 39.5x forward P/E ratio with steady growth expected. SpaceX shows explosive revenue growth (33% YoY) but faces significant challenges with a -26.4% net margin, -$14B free cash flow, and an extremely high 200x forward P/E valuation. The article recommends GE Aerospace as the more prudent long-term investment due to its established market position, profitability, and government support, while cautioning that SpaceX remains a high-risk, high-growth speculation.
- Zacks Investment Research·
Is GE Aerospace (GE) Outperforming Other Aerospace Stocks This Year?
GE Aerospace and Rolls-Royce Holdings PLC have outperformed the broader Aerospace sector year-to-date, with GE returning 1.4% versus a sector average loss of 11.7%, and Rolls-Royce up 23.2%. Both stocks hold Zacks Rank #2 (Buy) ratings with improving analyst sentiment and positive earnings estimate revisions.
- Zacks Investment Research·
GE Aerospace (GE) is Attracting Investor Attention: Here is What You Should Know
GE Aerospace has attracted investor attention with strong earnings growth expectations of +24.2% for the current fiscal year and +14.3% for the next year. The company has a Zacks Rank #2 (Buy) rating based on positive earnings estimate revisions. However, the stock has underperformed the broader market, down 5.2% over the past month, and trades at a premium valuation (D grade) compared to peers.
- Zacks Investment Research·
Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock?
Economic data shows mixed signals with softer-than-expected PCE inflation and stronger-than-expected Q2 GDP growth. Market attention is turning to Friday's employment report. Precigen shares surged 6.3% on growing investor confidence in sales of its FDA-approved drug Papzimeos for recurrent respiratory papillomatosis, with expected quarterly earnings up 181.8% year-over-year.
- The Motley Fool·
GE Vernova's CEO Just Delivered Great News to Shareholders
GE Vernova's CEO Scott Strazik delivered bullish remarks at a Morgan Stanley conference, highlighting accelerating backlog growth, stronger-than-expected power orders, margin expansion across all segments, and a profitability turnaround in the wind business. The company is pulling forward its $200 billion backlog milestone to early 2027 and expects larger margin expansion in 2026 than the double-digit gains achieved in 2025.
- GlobeNewswire Inc.·
Theriva™ Biologics anuncia la publicación en Nature Medicine de los resultados del ensayo clínico de Fase 2b VIRAGE con VCN-01 en el cáncer de páncreas metastásico
Theriva Biologics announced the publication of Phase 2b VIRAGE trial results in Nature Medicine, showing that VCN-01 (zabilugene almadenorepvec) combined with standard chemotherapy improved overall survival, progression-free survival, and response duration in metastatic pancreatic cancer patients compared to chemotherapy alone. The company is now conducting the VIRAGE2 Phase 2a trial to evaluate more frequent dosing of VCN-01, with initial data expected in Q3 2027. VCN-01 has received orphan drug and rare pediatric disease designations.
- Zacks Investment Research·
GE HealthCare (GEHC) Upgraded to Buy: Here's Why
GE HealthCare Technologies (GEHC) received an upgrade to Zacks Rank #2 (Buy) based on upward trends in earnings estimates. The company is expected to earn $4.93 per share for fiscal year 2026, with analysts steadily raising estimates over the past three months. The upgrade positions GEHC in the top 20% of Zacks-covered stocks, suggesting potential for near-term stock price appreciation driven by improving business fundamentals.
- Zacks Investment Research·Neutral
Here is What to Know Beyond Why GE Vernova Inc. (GEV) is a Trending Stock
GE Vernova (GEV), the energy business spun off from General Electric, has outperformed the S&P 500 with a +7.1% return over the past month. The company is expected to report strong earnings growth of +148.8% year-over-year for the current quarter and +72.4% for the fiscal year, with revenue growth of +21.6%. However, the stock carries a Zacks Rank #3 (Hold) rating and is trading at a premium valuation (Grade D) relative to peers, suggesting it may perform in line with the broader market in the near term.
- Zacks Investment Research·
Zacks Industry Outlook Highlights GE Aerospace, RTX and Howmet Aerospace
The Aerospace-Defense industry benefits from rising geopolitical tensions, higher military spending, and continued air-travel demand, though supply-chain constraints and labor shortages remain headwinds. GE Aerospace, RTX Corp., and Howmet Aerospace are highlighted as leading companies poised for growth, with all three carrying Zacks Rank #2 (Buy) ratings. However, the industry overall ranks #179 among 247 Zacks industries and has underperformed the S&P 500 by 31.2% over the past year.